This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laine, H. Articles by Knuuti, J. Search for Related Content PubMed PubMed Citation Articles by Laine, H. Articles by Knuuti, J.

(Circulation. 1999;100:2425.)
© 1999 American Heart Association, Inc.

Clinical Investigation and Reports

Myocardial Oxygen Consumption Is Unchanged but Efficiency Is Reduced in Patients With Essential Hypertension and Left Ventricular Hypertrophy

Hanna Laine, MD; Chietsugu Katoh, MD; Matti Luotolahti, MD; Hannele Yki-Järvinen, MD; Ilkka Kantola, MD; Antti Jula, MD; Teemu O. Takala, MD; Ulla Ruotsalainen, PhD; Hidehiro Iida, DSc; Merja Haaparanta, Msc; Pirjo Nuutila, MD; Juhani Knuuti, MD

From the Departments of Medicine (H.L., I.K., P.N.), and Clinical Physiology (M.L.), University of Turku; Turku PET Centre (C.K., T.O.T., U.R., M.H., J.K.); Research and Development Centre (A.J.), Social Insurance Institution, Turku, Finland; Research Center for Brain and Blood Vessels (H.I.), Akita, Japan; and Department of Medicine (H.Y.-J.), University of Helsinki, Finland.

Correspondence to Hanna Laine, MD, Department of Medicine, Turku University Central Hospital, PO Box 52, FIN-20521 Turku, Finland. E-mail hannal{at}pet.tyks.fi

Background—Patients with hypertension and left ventricular hypertrophy (LVH) are prone to develop heart failure. We tested the hypothesis that compensatory LVH is associated with normalization of myocardial oxygen consumption and that this occurs at the expense of a decrease in the ratio between cardiac work and oxygen consumption (efficiency).

Methods and Results—Nine hypertensive men with LVH (LVH+) (age 42±2 years), left ventricular mass index (LVMI) 161±8 g/m², blood pressure (BP) 145±16/88±10 mm Hg (mean±SD); 8 hypertensive men without LVH (LVH-) (age 39±5 years, LVMI 107±15 g/m², BP 140±15/90±11 mm Hg); and 10 normotensive men (CONT) were studied. Myocardial blood flow, oxygen consumption, and glucose uptake were measured during euglycemic hyperinsulinemia using PET techniques. LV dimensions, volumes, and workload were determined by echocardiography, and efficiency was calculated. Myocardial workload (2.5±0.8 versus 3.0±0.6 versus 2.3±0.5 mm Hg · mL · min^-1 · g^-1 for CONT versus LVH- versus LVH+; P<0.05, LVH- versus LVH+), myocardial blood flow (0.84±0.16 versus 1.06±0.22 versus 0.81±0.09 mL · g^-1 · min, respectively; P<0.05, LVH- versus other groups) and oxygen consumption (0.09±0.02 versus 0.14±0.03 versus 0.11±0.01 ml · g^-1 · min^-1, respectively; P<0.05, LVH- versus other groups) were increased in the LVH- group. Myocardial efficiency was reduced in the LVH+ group (18.1±4.1% versus 15.1±2.3% versus 13.5±1.9%, respectively; P<0.05, LVH+ versus CONT).

Conclusions—Myocardial oxygen consumption per unit weight is increased in hypertensive patients without LVH but is normal in those with LVH. The normalization of oxygen consumption via hypertrophy occurs at the expense of efficiency, which may predispose hypertensive patients with LVH to heart failure.

Key Words: hypertension • hypertrophy • oxygen • metabolism • imaging

This article has been cited by other articles:

				J. J. Lehman, S. Boudina, N. H. Banke, N. Sambandam, X. Han, D. M. Young, T. C. Leone, R. W. Gross, E. D. Lewandowski, E. D. Abel, et al. The transcriptional coactivator PGC-1{alpha} is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H185 - H196. [Abstract] [Full Text] [PDF]

				A. I. Duncan, B. S. Lowe, M. J. Garcia, M. Xu, A. M. Gillinov, T. Mihaljevic, and C. G. Koch Influence of Concentric Left Ventricular Remodeling on Early Mortality After Aortic Valve Replacement Ann. Thorac. Surg., June 1, 2008; 85(6): 2030 - 2039. [Abstract] [Full Text] [PDF]

				P. Knaapen, T. Germans, J. Knuuti, W. J. Paulus, P. A. Dijkmans, C. P. Allaart, A. A. Lammertsma, and F. C. Visser Myocardial Energetics and Efficiency: Current Status of the Noninvasive Approach Circulation, February 20, 2007; 115(7): 918 - 927. [Full Text] [PDF]

				C. S. Smith, P. A. Bottomley, S. P. Schulman, G. Gerstenblith, and R. G. Weiss Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium Circulation, September 12, 2006; 114(11): 1151 - 1158. [Abstract] [Full Text] [PDF]

				J. Scheuer Fueling the Hypertrophied Heart Hypertension, November 1, 2004; 44(5): 623 - 624. [Full Text] [PDF]

				L. R. Peterson, P. Herrero, K. B. Schechtman, S. B. Racette, A. D. Waggoner, Z. Kisrieva-Ware, C. Dence, S. Klein, J. Marsala, T. Meyer, et al. Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women Circulation, May 11, 2004; 109(18): 2191 - 2196. [Abstract] [Full Text] [PDF]

				M. Scorsin, A. Mebazaa, N. A. Attar, B. Medini, J. Callebert, R. Raffoul, R. Ramadan, J. M. Maillet, A. Ruffenach, F. Simoneau, et al. Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1022 - 1029. [Abstract] [Full Text] [PDF]

				R. J. Gropler Noninvasive measurements of myocardial oxygen consumption--can we do better? J. Am. Coll. Cardiol., February 5, 2003; 41(3): 468 - 470. [Full Text] [PDF]